Bupivacaine Patent Expiration
Bupivacaine is Used for providing local or regional analgesia in various surgical procedures and postoperative pain management. It was first introduced by Pacira Pharmaceuticals Inc
Bupivacaine Patents
Given below is the list of patents protecting Bupivacaine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Exparel | US12156940 | Manufacturing of bupivacaine multivesicular liposomes | Jul 02, 2044 | Pacira Pharms Inc |
| Exparel | US12251468 | Manufacturing of bupivacaine multivesicular liposomes | Jul 02, 2044 | Pacira Pharms Inc |
| Exparel | US12318483 | Manufacturing of bupivacaine multivesicular liposomes | Jul 02, 2044 | Pacira Pharms Inc |
| Exparel | US12370142 | Jul 02, 2044 | Pacira Pharms Inc | |
| Exparel | US11918565 | Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions | Feb 02, 2043 | Pacira Pharms Inc |
| Exparel | US12226610 | Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions | Feb 02, 2043 | Pacira Pharms Inc |
| Exparel | US11931459 | Treatment of pain in pediatric patients by administration of sustained-release liposomal anesthetic compositions | Mar 17, 2042 | Pacira Pharms Inc |
| Exparel | US11033495 | Manufacturing of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Exparel | US11179336 | Manufacturing of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Exparel | US11278494 | Manufacturing of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Exparel | US11304904 | Manufacturing of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Exparel | US11311486 | Manufacturing of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Exparel | US11357727 | Manufacturing of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Exparel | US11426348 | Compositions of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Exparel | US11452691 | Compositions of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Exparel | US11819574 | Manufacturing of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Exparel | US11819575 | Manufacturing of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Exparel | US11925706 | Manufacturing of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Exparel | US12144890 | Manufacturing of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Exparel | US12151024 | Manufacturing of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Exparel | US12296047 | Manufacturing of bupivacaine multivesicular liposomes | Jan 22, 2041 | Pacira Pharms Inc |
| Posimir | US11400019 | Sustained release drug delivery systems with reduced impurities and related methods | Jan 12, 2041 | Innocoll |
| Posimir | US11771624 | Sustained release drug delivery systems with reduced impurities and related methods | Jan 12, 2041 | Innocoll |
| Posimir | US8153149 | Controlled delivery system |
Sep 15, 2025
(Expired) | Innocoll |
| Posimir | US8153661 | Controlled delivery system |
Sep 15, 2025
(Expired) | Innocoll |
| Posimir | US8753665 | Controlled delivery system |
Sep 15, 2025
(Expired) | Innocoll |
| Posimir | US8846072 | Controlled delivery system |
Sep 15, 2025
(Expired) | Innocoll |
| Exparel | US9585838 | Production of multivesicular liposomes |
Dec 24, 2021
(Expired) | Pacira Pharms Inc |
| Exparel | US8182835 | Sustained-release liposomal anesthetic compositions |
Sep 18, 2018
(Expired) | Pacira Pharms Inc |
| Exparel | US8834921 | Sustained-release liposomal anesthetic compositions |
Sep 18, 2018
(Expired) | Pacira Pharms Inc |
| Exparel | US9205052 | Sustained-release liposomal anesthetic compositions |
Sep 18, 2018
(Expired) | Pacira Pharms Inc |
| Exparel | US6132766 | Multivesicular liposomes with controlled release of encapsulated biologically active substances |
Nov 16, 2013
(Expired) | Pacira Pharms Inc |
About Veterinary Bupivacaine
Bupivacaine is used in a drug marketed by 1 company: Elanco Us Inc.
Other drugs containing Bupivacaine are: Nocita .
Veterinary Bupivacaine Patents
Given below is the list of patents protecting Bupivacaine, along with the drug name that holds that patent and the company owning that drug.
Bupivacaine's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Bupivacaine:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
